Drug intelligence / Profile preview

betamethasone + gentamicin + tolnaftate + clioquinol

Development stage
Unknown
Lead developer
Syncom Formulation
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical, Otic
01

Overview

Betamethasone + gentamicin + tolnaftate + clioquinol is a topical pharmaceutical combination used to treat skin infections, particularly those involving mixed bacterial and fungal pathogens. The formulation combines four active ingredients with complementary mechanisms of action: - **Betamethasone** is a potent corticosteroid that exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by blocking the production of pro-inflammatory mediators such as prostaglandins. - **Gentamicin** is an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, providing broad-spectrum antibacterial activity against both Gram-positive and Gram-negative organisms. - **Tolnaftate** is an antifungal agent that disrupts fungal cell membrane function, inhibiting the growth of dermatophytes responsible for superficial mycoses. - **Clioquinol (iodochlorhydroxyquinoline)** acts as both an antifungal and antibacterial agent by interfering with microbial DNA replication and enzyme systems. This combination is indicated for inflammatory dermatoses complicated by secondary infection or when such infection risk exists. It may be prescribed for conditions like chronic dermatitis, eczema with superinfection, intertrigo, tinea pedis/cruris/corporis (fungal infections), impetigo, neurodermatitis, paronychia, minor infected wounds or burns[1][2][4][6].

Brand names
QuadridermFungibanQuatroderm
Other names
betamethasone valerate + gentamicin sulfate + tolnaftate + clioquinolbetamethasone valerate + gentamicin sulfate + tolnaftate + iodochlorhydroxyquinoline
02

Targets

Bacterial RibosomeSQLE (Squalene monooxygenase)GR (Glucocorticoid receptor)Bacterial DNA topoisomerase

Beyond the preview

Go deeper on betamethasone + gentamicin + tolnaftate + clioquinol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on betamethasone + gentamicin + tolnaftate + clioquinol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call